Michael Baer, MD

Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
View 1 additional location
Headshot of Michael Baer, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Neurology

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Pennsylvania Hospital
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

560 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
June 2026
the md provided clear explanations of my situation and concerns
Anonymous
May 2026
dr baer was very thorough... took the time to go over the records i brought and took the time to explain everything to us.
Anonymous
May 2026
he took his time
Anonymous
May 2026
excellent care.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baer is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Rhodes E, Alfa S, Jin HA, Massimo L, Elman L, Amado D, Baer M, Quinn C, McMillan CT Cognitive reserve in ALS: the role of occupational skills and requirements , Amyotroph Lateral Scler Frontotemporal Degener, 25(5-6): 2024,486-495


Quinn C, Baer M, Amado DA, Kelley M, Elman L A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiol , Muscle & Nerve, 70(1): 2024,1-4


Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts , J Neurol, 271(2): 2024,733-747


Shen T, Vogel JW, Duda J, Phillips JS, Cook PA, Gee J, Elman L, Quinn C, Amado DA, Baer M, Massimo L, Grossman M, Irwin DJ, McMillan CT Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum , Transl Neurodegener, 12(1): 2023,57


Laughlin RS, Adkins S, Baer M, Dehbashi S, Gable K, Govindarajan R, Guidon AC, Gwathmey KG, Hehir MK, Imperioli M, Price RS, Sakamuri S, Sokol J, Tiongson N, Wong ES, London Z The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process , Neurol Educ., 2(3): 2023,e200086


London ZN, Gable KL, Govindarajan R, Guidon AC, Gwathmey KG, Hehir MK, Imperioli M, Laughlin RS, Price RS, Sakamuri S, Sokol J, Baer M The neuromuscular fellowship portal and match , Muscle Nerve, 65(6): 2022,640-645


Michael Baer, Lauren Elman Predicting Ethical Issues from Potential Advances in ALS Genetically Mediated Therapies , Neurology : 2022


Michael Baer and Colin Quinn Advance Care Planning in Amyotrophic Lateral Sclerosis , Practical Neurology : 2021,28-31


Placek K, Baer GM, Elman L, McCluskey L, Hennessy L, Ferraro PM, Lee EB, Lee VMY, Trojanowski JQ, Van Deerlin VM, Grossman M, Irwin DJ, McMillan CT. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. , Neurobiol Aging., 73: 2019,190-199


Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM, Irwin DJ, Van Deerlin VM, Trojanowski JQ. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. , Acta Neuropathol., 134(1): 2017,65-78